Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Bain Capital offers $25.75 per share to fully acquire Surgery Partners
Bain Capital Private Equity announced a proposal to acquire the remaining shares of Surgery Partners, offering $25.75 per share. Bain Capital, which already owns 39% of the company, plans to take full control of the surgical facility operator in a deal that represents...
Actis sells Java House to two Africa-focused private equity firms
Africa-focused private equity firms Alterra Capital and Phatisa Group will acquire Java House, Kenya’s leading coffee and casual dining chain, from Actis, a London-based private equity firm. Mauritius-based Alterra will hold the majority stake in the transaction,...
Warburg Pincus and CVC compete for $3bn stake in Philippines’ largest private hospital group
Global private equity firms Warburg Pincus, CVC Capital Partners, and TPG are vying to acquire a stake in Metro Pacific Hospital Holdings, the largest private hospital operator in the Philippines. The transaction, estimated at $3bn, highlights growing private equity...